Pulmonx Total Assets 2019-2025 | LUNG

Pulmonx total assets from 2019 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Pulmonx Annual Total Assets
(Millions of US $)
2024 $163
2023 $178
2022 $194
2021 $235
2020 $264
2019 $54
2018 $15
Pulmonx Quarterly Total Assets
(Millions of US $)
2025-03-31 $151
2024-12-31 $163
2024-09-30 $167
2024-06-30 $173
2024-03-31 $165
2023-12-31 $178
2023-09-30 $185
2023-06-30 $193
2023-03-31 $201
2022-12-31 $194
2022-09-30 $202
2022-06-30 $213
2022-03-31 $223
2021-12-31 $235
2021-09-30 $247
2021-06-30 $249
2021-03-31 $255
2020-12-31 $264
2020-09-30 $71
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2018-12-31 $15
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.126B $0.084B
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.320B 52.93
Hims & Hers Health (HIMS) United States $11.979B 124.46
Tempus AI (TEM) United States $10.204B 0.00
IRhythm Technologies (IRTC) United States $4.547B 0.00
Inspire Medical Systems (INSP) United States $4.305B 67.26
Privia Health (PRVA) United States $2.816B 192.50
Enovis (ENOV) United States $1.849B 10.31
Clover Health Investments (CLOV) United States $1.669B 0.00
Schrodinger (SDGR) United States $1.550B 0.00
Phreesia (PHR) United States $1.447B 0.00
Omnicell (OMCL) United States $1.351B 23.83
Azenta (AZTA) United States $1.283B 59.64
10x Genomics (TXG) United States $1.052B 0.00
Fulgent Genetics (FLGT) United States $0.625B 0.00
Butterfly Network (BFLY) United States $0.529B 0.00
Claritev (CTEV) United States $0.479B 0.00
Veradigm (MDRX) United States $0.476B 0.00
Talkspace (TALK) United States $0.462B 138.00
Standard BioTools (LAB) United States $0.363B 0.00
TruBridge (TBRG) United States $0.356B 789.67
Outset Medical (OM) United States $0.327B 0.00
Nyxoah SA (NYXH) Belgium $0.283B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.193B 0.00
EUDA Health Holdings (EUDA) Singapore $0.136B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.097B 0.00
CareCloud (CCLD) United States $0.087B 3.31
111 (YI) China $0.067B 0.00
P3 Health Partners (PIII) United States $0.055B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Retrieve Medical Holdings (RMHI) United States $0.051B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00